Blackrock Muni New York Interme (MNE) Forms $13.74 Double Top; Aviragen Therapeutics (AVIR) Sellers Increased By 45.61% Their Shorts

Blackrock Muni New York Interme (MNE) formed double top with $14.70 target or 7.00% above today’s $13.74 share price. Blackrock Muni New York Interme (MNE) has $57.84 million valuation. The stock increased 0.37% or $0.05 during the last trading session, reaching $13.74. About 200 shares traded. Blackrock Muni New York Interme (NYSE:MNE) has declined 9.63% since January 5, 2017 and is downtrending. It has underperformed by 26.33% the S&P500.

Aviragen Therapeutics Incorporated (NASDAQ:AVIR) had an increase of 45.61% in short interest. AVIR’s SI was 278,700 shares in January as released by FINRA. Its up 45.61% from 191,400 shares previously. With 468,500 avg volume, 1 days are for Aviragen Therapeutics Incorporated (NASDAQ:AVIR)’s short sellers to cover AVIR’s short positions. The SI to Aviragen Therapeutics Incorporated’s float is 0.91%. The stock decreased 0.16% or $0.0009 during the last trading session, reaching $0.5592. About 10,624 shares traded. Aviragen Therapeutics, Inc. (NASDAQ:AVIR) has declined 68.31% since January 5, 2017 and is downtrending. It has underperformed by 85.01% the S&P500.

Investors sentiment decreased to 0.3 in Q3 2017. Its down 0.20, from 0.5 in 2017Q2. It dropped, as 2 investors sold Blackrock Muni New York Interme shares while 8 reduced holdings. 2 funds opened positions while 1 raised stakes. 468,684 shares or 13.45% less from 541,511 shares in 2017Q2 were reported. 12,977 are owned by Mariner Ltd Company. Ontario – Canada-based Royal Fincl Bank Of Canada has invested 0% in Blackrock Muni New York Interme (NYSE:MNE). Joel Isaacson Limited Liability holds 0.03% of its portfolio in Blackrock Muni New York Interme (NYSE:MNE) for 10,000 shares. Raymond James Financial Advsr invested 0% of its portfolio in Blackrock Muni New York Interme (NYSE:MNE). Invesco Ltd holds 0% or 69,676 shares. Morgan Stanley reported 56,288 shares or 0% of all its holdings. Karpus has invested 0.04% of its portfolio in Blackrock Muni New York Interme (NYSE:MNE). Bancshares Of America Corp De holds 0% or 139,465 shares in its portfolio. Focused Wealth reported 13,351 shares or 0.06% of all its holdings. Moreover, Horizon Kinetics Limited Liability Corporation has 0.01% invested in Blackrock Muni New York Interme (NYSE:MNE) for 25,197 shares. Wells Fargo And Mn holds 7,704 shares or 0% of its portfolio. Wolverine Asset Management invested in 0% or 22,146 shares. Raymond James Assoc holds 0% or 10,345 shares in its portfolio.

Aviragen Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of direct-acting antivirals to treat infections that have limited therapeutic options and affect patients worldwide. The company has market cap of $21.61 million. The Company’s product candidates that are in phase II clinical stage development include BTA074, an antiviral treatment for condyloma caused by human papillomavirus types 6 and 11; Vapendavir, a potent antiviral capsid binder for human rhinovirus upper respiratory infections in moderate-to-severe asthmatics; and BTA585, an oral fusion protein inhibitor for the treatment and prevention of respiratory syncytial virus infections. It currently has negative earnings. The firm also has a preclinical RSV non-fusion inhibitor program.